From Quantum Mechanics to Population Health Modeling
By: Daniel R. Matlis, President
“The Holy Grail of Life Science and Healthcare is the development of a virtual human model; to enable medical experiments in-silico, rather than in-vivo[i].” That was the opening line of my 2015 Dassault Systèmes Analyst Conference Brief: “Medical Experiments on your Digital Twin”
At this year’s conference, Dassault Systèmes demonstrated that they are at the forefront of engineering the Precision Medicine Revolution. The company’s goal is to unify the real and virtual worlds, to optimize Patient and Physician experience through the best collaborative science.
Healthcare is shifting away from episodic care at a hospital or a medical practitioner’s office. There is also a movement away from the traditional reactive model healthcare to proactively addressing potential issues and offering preventive care. This is driving Life-Science organizations to engineer more holistic and personalized approaches to care.
According to Bernard Charlès, Chief Executive Officer of Dassault Systèmes, “As society seeks personalized health while ensuring optimum industrial security, the time has come for Life Sciences to at last leverage the tremendous power of the virtual world. Digital environments are pushing the bounds of possibility to transform research, science, the pharmaceutical industry, and medicine in general. As we enter the age of the experience economy, innovation is driven by consumer and patient experience.[ii].”
At the conference, Dassault Systemes presented how Life Science organizations are using digital solutions to engineer Precision Medicine solutions by unleashing innovation through a collaborative, multidiscipline, multiscale scientific environment in order to optimize patient and physician experience.
The use of the 3DEXPERIENCE platform enables cross-disciplinary collaboration, allowing teams of researchers, physicians, scientists, medicinal chemists and engineers to conduct in-silico 3D experiments.
The platform allows the design and testing of in-silico 3D experiments based on virtual models, informed by Real World Evidence. This allows the simulation of healthcare scenarios, ranging from quantum mechanics to organ simulation through population health modeling, that would not be possible to test in the real world.
This approach can accelerate time to market, facilitate regulatory requirements, maximize efficacy, and deliver next generation products to more physicians and patients at lower costs.
Conclusion
Dassault Systèmes continues to deliver on its vision to utilize the 3DEXPERIENCE platform to improve human life. The company strives to utilize the experiences and knowledge it has gained in its core industries, such as Aerospace & Defense and Transportation & Mobility, to drive innovation in Life Science and Healthcare by engineering the Precision Medicine Revolution
The ability perform in-silico 3D experiments, offers the promise to accelerate the delivery of next generation products to more physicians and patients at lower costs.
The future looks bright for Precision Medicine. We will continue to monitor and report how Dassault Systèmes executes on its commitment to making its vision a reality for its customers and ultimately, the patient.
[i] Medical Experiments on your Digital Twin https://axendia.com/blog/2015/07/28/medical-experiments-on-your-digital-twin/
[ii] https://www.3ds.com/fileadmin/COMPANY/Investors/Annual-Reports/PDF/2016-3DS-Corporate-Report-spreads-EN.pdf